Arizona State Retirement System’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Buy |
86,392
+14,896
| +21% | +$75.4K | ﹤0.01% | 1528 |
|
|
2025
Q1 | $378K | Sell |
71,496
-239
| -0.3% | -$1.26K | ﹤0.01% | 1554 |
|
|
2024
Q4 | $485K | Buy |
71,735
+19,063
| +36% | +$129K | ﹤0.01% | 1491 |
|
|
2024
Q3 | $347K | Buy |
52,672
+4,981
| +10% | +$32.8K | ﹤0.01% | 1689 |
|
|
2024
Q2 | $358K | Buy |
47,691
+4,760
| +11% | +$35.7K | ﹤0.01% | 1615 |
|
|
2024
Q1 | $428K | Buy |
42,931
+3,005
| +8% | +$30K | ﹤0.01% | 1531 |
|
|
2023
Q4 | $394K | Buy |
39,926
+3,125
| +8% | +$30.8K | ﹤0.01% | 1588 |
|
|
2023
Q3 | $282K | Buy |
36,801
+733
| +2% | +$5.61K | ﹤0.01% | 1709 |
|
|
2023
Q2 | $269K | Buy |
36,068
+20,274
| +128% | +$151K | ﹤0.01% | 1780 |
|
|
2023
Q1 | $105K | Buy |
15,794
+1,815
| +13% | +$12.1K | ﹤0.01% | 2104 |
|
|
2022
Q4 | $108K | Buy |
13,979
+622
| +5% | +$4.8K | ﹤0.01% | 2094 |
|
|
2022
Q3 | $142K | Buy |
13,357
+388
| +3% | +$4.13K | ﹤0.01% | 2014 |
|
|
2022
Q2 | $106K | Buy |
12,969
+2,188
| +20% | +$17.9K | ﹤0.01% | 2106 |
|
|
2022
Q1 | $77K | Buy |
10,781
+81
| +0.8% | +$579 | ﹤0.01% | 2191 |
|
|
2021
Q4 | $183K | Buy |
+10,700
| New | +$183K | ﹤0.01% | 2106 |
|